Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002325 · ClinicalTrials.gov registry record · NA
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002325 is a NA study that has completed, run by Pfizer.
The verdict
NCT00002325, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts \< 250 cells/mm3 who are living in the coccidioidal endemic area.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002325
The ClinicalTrials.gov registry entry for NCT00002325 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00002325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002325 about?
NCT00002325 is a clinical study titled "A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common". To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts \< 250 cells/mm3 who are living in the coccidioidal endemic area.
What is the current status of trial NCT00002325?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002325?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002325?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.